Literature DB >> 15538572

[Postmortal diagnosis of Parkinson's disease].

D Sandmann-Keil1, H Braak.   

Abstract

Parkinson's disease is a continuously progressive degenerative disorder of the central, peripheral and enteric human nervous systems. Not only the substantia nigra, but also a number of other components of the motor and limbic systems, as well as the autonomic regulation, suffer heavy damages. Only a few of the many types of nerve cells in the human central nervous system develop the characteristic Lewy bodies and Lewy neurites. They are composed primarily of aggregated alpha-synuclein and lead to the premature destruction of the affected neurons. Due to the selective neuronal vulnerability, a distinctive distribution of changes occurs within the central nervous system, leading to a corresponding loss of functionality in many systems. The changes occur in an ordered timely fashion. The ascending pathological process begins within the brain at the glossopharyngeal and vagal areas, nearly destroys the substantia nigra, and reaches the mesocortex of the gray matter. From here it expands to further areas of the neocortex, thereby marking the end phase of the disease.

Entities:  

Mesh:

Year:  2005        PMID: 15538572     DOI: 10.1007/s00292-004-0722-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  37 in total

Review 1.  Nigral and extranigral pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; C Schultz; R A de Vos; E N Jansen
Journal:  J Neural Transm Suppl       Date:  1995

Review 2.  Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.

Authors:  J Q Trojanowski; V M Lee
Journal:  Arch Neurol       Date:  1998-02

3.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

4.  Where does parkinson disease pathology begin in the brain?

Authors:  Kelly Del Tredici; Udo Rüb; Rob A I De Vos; Jürgen R E Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2002-05       Impact factor: 3.685

Review 5.  Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.

Authors:  W H Oertel
Journal:  Arzneimittelforschung       Date:  1995-03

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 7.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

Review 8.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

Authors:  D F Clayton; J M George
Journal:  Trends Neurosci       Date:  1998-06       Impact factor: 13.837

Review 9.  [Etiology of Parkinson disease. An epidemiologic perspective with possible implications for prevention].

Authors:  W Hellenbrand; P Vieregge; B P Robra; P Nischan; J Glass; P Haagen; J Jörg; W H Oertel; E Schneider; G Ulm
Journal:  Nervenarzt       Date:  1993-12       Impact factor: 1.214

Review 10.  Neuropathology of the substantia nigra.

Authors:  W R Gibb
Journal:  Eur Neurol       Date:  1991       Impact factor: 1.710

View more
  1 in total

1.  Proteome analysis of human substantia nigra in Parkinson's disease.

Authors:  Cornelius J Werner; Roland Heyny-von Haussen; Gerhard Mall; Sabine Wolf
Journal:  Proteome Sci       Date:  2008-02-14       Impact factor: 2.480

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.